MESORIDAZINE

被引：0
|
作者：
不详
机构：
来源：
DRUG INTELLIGENCE & CLINICAL PHARMACY | 1971年 / 5卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：84 / &
相关论文
共 50 条
  • [31] A COMPARISON OF MESORIDAZINE AND CHLORPROMAZINE IN CHRONIC PSYCHIATRIC PATIENTS
    DOUGLAS, KW
    HINDLEY, JP
    JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1969, 9 (03): : 176 - &
  • [32] CLINICAL EVALUATION OF MESORIDAZINE IN MENTALLY RETARDED PATIENTS
    ZALESKI, WA
    CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1970, 15 (03): : 319 - 322
  • [33] EFFECTS OF NORTRIPTYLINE AND MESORIDAZINE ON NEURONS AND GLIA INVITRO
    GRUNNET, ML
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1977, 36 (05): : 835 - 841
  • [34] METHOD FOR MEASURING THIORIDAZINE, MESORIDAZINE AND THEIR METABOLITES IN PLASMA
    DINOVO, EC
    GOTTSCHALK, LA
    NANDI, BR
    GEDDES, PG
    CLINICAL CHEMISTRY, 1975, 21 (07) : 974 - 974
  • [35] TARDIVE TOURETTES SYNDROME TREATED WITH CLONIDINE AND MESORIDAZINE
    MUNETZ, MR
    SLAWSKY, RC
    NEIL, JF
    PSYCHOSOMATICS, 1985, 26 (03) : 254 - &
  • [36] A CLINICAL TRIAL WITH MESORIDAZINE (ANOTHER PHENOTHIAZINE DERIVATIVE)
    RUDY, L
    MAROZAS, RJ
    SYKES, D
    SMITH, JA
    DISEASES OF THE NERVOUS SYSTEM, 1968, 29 (06): : 412 - &
  • [37] COMBINED MESORIDAZINE AND AMANTADINE TREATMENT IN REFRACTORY SCHIZOPHRENICS
    OPLER, LA
    KAY, SR
    VITALHERNE, J
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 37 (02): : 318 - 325
  • [38] MESORIDAZINE (TPS-23) A NEW ANTIPSYCHOTIC DRUG
    PRUSMACK, JJ
    HOLLISTER, LE
    OVERALL, JE
    SHELTON, J
    JOURNAL OF NEW DRUGS, 1966, 6 (03): : 182 - +
  • [39] MESORIDAZINE IN TREATMENT OF FUNCTIONAL SEXUAL DISORDERS IN MALE PATIENTS
    MOLCAN, J
    ACTIVITAS NERVOSA SUPERIOR, 1968, 10 (03): : 261 - &
  • [40] IDENTIFICATION OF A METABOLITE OF THIORIDAZINE AND MESORIDAZINE FROM HUMAN PLASMA
    GRUENKE, LD
    CRAIG, JC
    DINOVO, EC
    GOTTSCHALK, LA
    NOBLE, EP
    BIENER, R
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1975, 10 (02): : 221 - 225
12345